The Center breaks with the conventional setting of discipline-oriented departments, and establishes disease-centered multidisciplinary specialty groups, and clusters basic research teams to jointly promote research on disease mechanisms, screening and diagnosis, and treatment modalities. This setting enables the Center to help patients select appropriate treatments, reduce referrals and examinations within medical institutions, lower medical costs, and improve patients' experience.
The Center has a group of multidisciplinary teams led by physician-scientists that consist of clinicians, basic researchers, pharmacists, statisticians and other multidisciplinary experts. With the mission of conducting clinical-problem-driven research, the Center identifies problems from clinical practice and relevant scientific questions, and develops treatment solutions and components, which then are fed back to the clinic for validation, evaluation and optimization.
The Center employs a treatment model that promotes the patients’ participation in order to create a human-centered medical experience, combining standardized diagnosis and treatment norms with personalized program selection. In addition to routine treatments, the Center actively develops molecular imaging probes, genetic testing, and drug technology to achieve individualization and precision of treatment through exploratory research, become an “incubator” for new drugs, devices and technology.
The Center carries out a patient-centered concept and provides patients with a full range of medical services from prevention, early screening of diseases, comprehensive treatment and continuous management by means of general medicine outpatient services, health management center, MDT consultation and specialty referral. The Department of General Medicine undertakes two-way referral of patients by closely linking with specialties to ensure the continuity and professionalism of disease management.
The Center provides operational diagnosis for outpatients by enabling some traditional inpatient medical services to be performed on an outpatient, day-patient basis, and integrates them in its Day Treatment Center by enlisting technology improvement, process optimization, and lean management, thereby reducing patients’ wait-time, optimizing medical experience, and providing patients with humanistic care and support.
The Center employs a smart data center as required by its clinical and management needs. Data integration management is a strategic configuration of enabling the clinical platform for open research, providing a comprehensive showcase for a new departmental integration and treatment model, demonstrating an exploration of deep integration of “medical, research, academics, translation”, as well as a perfect demonstration of advanced information systems to achieve hospital intelligence.
The clinical team of the Center for Neurological Diseases is made up of doctors specialising in neurology, neurosurgery, neurocritical medicine, geriatrics, rheumatology, psychology, imaging, interventional medicine and pathology.
The clinical medicine team of the Oncology Center consists of doctors from the departments of Medical Oncology, Gastroenterology, Respiratory Medicine, General Surgery, Thoracic Surgery, Urology, Imaging, Radiotherapy, Interventional Medicine, Pathology and Laboratory Medicine.
The clinical team of the Center for Panvascular Diseases is made up of doctors specialising in cardiovascular medicine/surgery, neurology/surgery, vascular surgery, rheumatology, imaging and interventional medicine.
The clinical medicine team of the Center for Respiratory Diseases consists of a combination of doctors specialising in respiratory medicine, respiratory intensive care medicine, thoracic surgery, allergology, geriatrics, and otorhinolaryngology.
The clinical team of the Center for Rheumatology, Immunology and Musculoskeletal Diseases consists of doctors from the departments of Rheumatology, Endocrinology, Orthopaedics, Geriatrics, Nephrology, Neurology, Dermatology, Imaging and Pathology.
The clinical team of the Center for Sensory System Diseases consists of a combination of ophthalmologists, otorhinolaryngologists, neurologists, endocrinologists, immunologists, allergists, respiratory physicians and dermatologists.
2024-12-20
2024-11-19
2024-11-11
2024-09-17
2024-07-12
Administration Office
2024-11-01
Administration Office
2024-03-01
Administration Office
2023-09-22
Administration Office
2023-05-10
Abiotic stresses such as drought, salinity, and extreme temperatures threaten global crop yields. For optimum crop productivity, plants must efficiently combat these stresses. Rapid accumulation of proline under stress is a key feature and primary defense strategy in plants. Arabidopsis thaliana pyrroline-5-carboxylate synthase (AtP5CS), involved in proline metabolism, serves as the rate-limiting enzyme for de novo proline synthesis in plants. AtP5CS contains both glutamate kinase (GK) and glutamate-5-semialdehyde dehydrogenase (GPR) domains.
Led by Professor Liu Ji-Long in the School of Life Science and Technology, a research team has recently made strides in comprehending the structure and inhibition mechanisms of prokaryotic cytidine triphosphate (CTP) synthase, as detailed in the academic journal mLife in a paper entitled “Filamentation and inhibition of prokaryotic CTP synthase with ligands” on May 2. This study provides novel insights into CTP synthase regulation within biological systems and lays groundwork for innovative therapeutic approaches against bacterial pathogens.
The testes are the site of sperm production and secretion of male hormones. Testicular aging not only leads to a decline in fertility but also significantly affects the quality of life for men. Late-onset hypogonadism (LOH) is a typical pathological change of testicular aging, characterized by testosterone deficiency and other related clinical symptoms. Prolonged testosterone deficiency can also cause metabolic syndrome, such as diabetes and hyperlipidemia, and the onset of diseases like Alzheimer’s, leading to a significant increase in mortality rates. The incidence of LOH
Hepatocellular carcinoma, a highly prevalent malignant tumor in China, accounts for nearly half of the newly diagnosed cases and deaths worldwide annually. Among liver cancer patients, 70-80% are diagnosed with tumor spread and metastasis, rendering them ineligible for surgical intervention. However, a comprehensive understanding of the molecular characteristics specific to metastatic liver cancer is still lacking.
